Device Trial Radar · NCT04964609
EmbracePlus SpO2 Accuracy Validation
Last checked: Nov 19, 2026Latest source record: Nov 25, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
14
Actual
Start
Jun 16, 2021
Primary completion
Nov 21, 2022
Study completion Nov 21, 2022
Sponsor
- Lead sponsor
- Empatica, Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Empatica Srl
- First posted
- Jul 16, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The aim of this study is to test the accuracy of EmbracePlus computed SpO2 during mild, moderate and severe hypoxia (a lower-than-normal concentration of oxygen in arterial blood); ie, a range of arterial HbO2 saturations from 100 to down to 70%. This is done by comparing the reading of the the subject device during brief, steady state hypoxia with a gold-standard measurement of blood oxyhemoglobin (hemoglobin carrying oxygen) saturation, that is arterial blood sample processed in a laboratory.
Conditions
- Oximetry
Interventions
EmbracePlusDevice
A device intended for use by researchers and healthcare professionals for continuous collection of physiological parameters in home and healthcare settings. Parallel blood gas analysis to determine oxyhemoglobin saturation (SaO2) using an ABL-90 multi-wavelength oximeter.
Primary outcomes
What the sponsor says the trial is designed to measure.
- SpO2 AccuracyTime frame: Through study completion, 3 months average
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Hypoxia Research Laboratory Department of Anesthesia and Perioperative Care University of California
San Francisco, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.